XNAS · GRAL

+7.11% · +$4.99 · Vol 730.4K

Market closed · last close 4:00 PM ET · price as of 17:55:25 ET

GRAIL, Inc. Common Stock

SERVICES-MEDICAL LABORATORIES

$75.13

+ Add to watchlist

Card

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

REFRESHES DAILY

AI Analysis

Sovereign

Why is GRAL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move GRAL next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Form 4 / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 9
Score
Score moved +17
59/NEUTRAL -> 76/STRONG
Veridion score historySource
Jun 22
Form 4Sovereign
Krevans Sarah Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 22
Form 4Sovereign
CHASE WILLIAM J Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 22
Form 4Sovereign
MIZELL STEVEN Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 22
Form 4Sovereign
SUMME GREGORY L Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 5
Form 4Sovereign
Partridge Andrew John Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 3
Form 4Sovereign
Ofman Joshua J. Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Apr 17
Form 4Sovereign
CHASE WILLIAM J Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Apr 17
Form 4Sovereign
MIZELL STEVEN Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Apr 17
Form 4Sovereign
SUMME GREGORY L Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt

Catalyst calendar

Dated receipts for GRAL are being assembled.

About GRAIL, Inc. Common Stock

SERVICES-MEDICAL LABORATORIES

Listed since

2024

Employees

910

Country

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$70.30

Day high

$76.00

Day low

$70.19

Previous close

$70.14

52W high

$76.00

-1.15% from high

52W low

$58.59

95% of range

Market cap

$3B

EPS

$-11.7900

Shares out

42.9M

Volume

730.4K

VWAP

$74.61

Price history computed in-house

+8.19%

+24.97%

SMA 50 $65.21 · above

SMA 200 $65.21 · above

52W position 95%

Veridion warehouse edge

Warehouse intelligence for GRAL.

Veridion Score

0: 501: 462: 783: 904: 725: 0

Congress 30d

No recent disclosure on file.

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

GRAL insider activity

GRAIL, Inc. Common Stock

Score

Coverage building

Pressure

Net selling

Filings

Buys / sells

20 / 35

Net value

-$99.6M

Insiders

Named filers

Krevans Sarah

Insider

Leadership

CHASE WILLIAM J

Insider

Leadership

MIZELL STEVEN

Insider

Leadership

Cluster

5 insiders bought in the last 90 days

Net pressure

Net selling: -$99.6M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing date	Trade date	Insider	Title	Type	Price	Qty	Owned	Value	Receipt
2026-06-22	2026-06-18	Krevans Sarah	Insider	buy	$63.74	5,491	42,628	$350K	SEC Form 4
2026-06-22	2026-06-18	CHASE WILLIAM J	Insider	buy	$63.74	5,491	42,702	$350K	SEC Form 4
2026-06-22	2026-06-18	MIZELL STEVEN	Insider	buy	$63.74	5,491	42,562	$350K	SEC Form 4
2026-06-22	2026-06-18	SUMME GREGORY L	Insider	buy	$63.74	5,491	45,245	$350K	SEC Form 4
2026-06-05	2026-06-04	Partridge Andrew John	Insider	sell	$61.08	1,491	163,738	$91K	SEC Form 4

Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 50 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Congress · 90D

Congress filing snapshot refresh in progress

Federal contracts

GRAL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for GRAL in this window.

Lobbying spend

GRAL lobbying filings, year to date.

Registered lobbying filings matched to GRAIL, Inc. Common Stock.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for GRAL in this window.

Cross-references from this score page.

Apprentice · 1 rail

Similar Score profile

Nearest score and factor neighbors with missing factor rows dropped.

Methodology